| Q44357425 | A 3,387 bp 5'-flanking sequence of the goat alpha-S1-casein gene provides correct tissue-specific expression of human granulocyte colony-stimulating factor (hG-CSF) in the mammary gland of transgenic mice. |
| Q61800268 | A Brief Reminder of Systems of Production and Chromatography-Based Recovery of Recombinant Protein Biopharmaceuticals |
| Q47174767 | A genome-wide study to identify genes responsible for oviduct development in chickens |
| Q61445443 | A milk-based self-assemble rotavirus VP6-ferritin nanoparticle vaccine elicited protection against the viral infection |
| Q53499744 | A new animal bioreactor for producing pharmaceutical proteins. |
| Q58765419 | A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle |
| Q56557417 | A novel recombinant human plasminogen activator: Efficient expression and hereditary stability in transgenic goats and in vitro thrombolytic bioactivity in the milk of transgenic goats |
| Q42227774 | A size-exclusion nanocellulose filter paper for virus removal |
| Q36158788 | Adeno-associated-virus-mediated transduction of the mammary gland enables sustained production of recombinant proteins in milk |
| Q58476142 | Advances in Protein Production Technologies |
| Q36310808 | Assessing Tn5 and Sleeping Beauty for transpositional transgenesis by cytoplasmic injection into bovine and ovine zygotes |
| Q57285329 | Avian Bioreactor Systems: A Review |
| Q30234979 | Avian embryos and related cell lines: A convenient platform for recombinant proteins and vaccine production |
| Q45868639 | Biochemical characterization of LR769, a new recombinant factor VIIa bypassing agent produced in the milk of transgenic rabbits |
| Q47324534 | Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding. |
| Q37138255 | Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori). |
| Q39288766 | Characterization of antibody variants during process development: the tale of incomplete processing of N-terminal secretion peptide |
| Q21004096 | Characterization of bioactive recombinant human lysozyme expressed in milk of cloned transgenic cattle |
| Q38837138 | Chlorella species as hosts for genetic engineering and expression of heterologous proteins: Progress, challenge and perspective. |
| Q37859086 | Chloroplast-derived vaccines against human diseases: achievements, challenges and scopes. |
| Q41674429 | Cloning and Expression of Iranian Turkmen-thoroughbred Horse Follicle Stimulating Hormone in Pichia pastoris |
| Q38465155 | Cloning and Molecular Characterization of Porcine β-casein Gene (CNS2). |
| Q37232036 | Comparison of Different Electroporation Parameters on Transfection Efficiency of Sheep Testicular Cells. |
| Q48250115 | Comparison of transplastomic Chlamydomonas reinhardtii and Nicotiana tabacum expression system for the production of a bacterial endoglucanase |
| Q33987983 | Could protein tertiary structure influence mammary transgene expression more than tissue specific codon usage? |
| Q33793459 | Cre-LoxP-regulated expression of monoclonal antibodies driven by an ovalbumin promoter in primary oviduct cells |
| Q52608297 | Detection of endoplasmic reticulum stress markers and production enhancement treatments in transgenic goats expressing recombinant human butyrylcholinesterase. |
| Q55613157 | Efficient production of human interferon beta in the white of eggs from ovalbumin gene-targeted hens. |
| Q34973614 | Epigenetic changes of lentiviral transgenes in porcine stem cells derived from embryonic origin. |
| Q54335262 | Expression of biologically active human interferon alpha 2b in the milk of transgenic mice. |
| Q82420988 | Expression of functional recombinant human growth hormone in transgenic soybean seeds |
| Q38126016 | Expression of recombinant antibodies |
| Q37405219 | Expression of recombinant human lysozyme in transgenic chicken promotes the growth of Bifidobacterium in the intestine and improves postnatal growth of chicken |
| Q43639956 | Expression of the human granulocyte-macrophage colony stimulating factor (hGM-CSF) gene under control of the 5'-regulatory sequence of the goat alpha-S1-casein gene with and without a MAR element in transgenic mice |
| Q39468670 | Expression systems and species used for transgenic animal bioreactors |
| Q57950254 | Extrapolating understanding of food risk perceptions to emerging food safety cases |
| Q27345423 | Generation of Transgenic Porcine Fibroblast Cell Lines Using Nanomagnetic Gene Delivery Vectors. |
| Q50234931 | Generation of transgenic cattle expressing human β-defensin 3 as an approach to reducing susceptibility to Mycobacterium bovis infection |
| Q55252265 | Generation of transgenic chickens expressing the human erythropoietin (hEPO) gene in an oviduct-specific manner: Production of transgenic chicken eggs containing human erythropoietin in egg whites. |
| Q40527248 | Genome Editing in Large Animals. |
| Q28082842 | Glycan analysis of therapeutic glycoproteins |
| Q91936459 | HMEJ-mediated efficient site-specific gene integration in chicken cells |
| Q44794707 | High level expression of recombinant human antithrombin in the mammary gland of rabbits by adenoviral vectors infection |
| Q42574263 | High-level expression and preparation of recombinant human fibrinogen as biopharmaceuticals |
| Q40657418 | High-level expression of a novel recombinant human plasminogen activator (rhPA) in the milk of transgenic rabbits and its thrombolytic bioactivity in vitro |
| Q34049531 | Human extracellular superoxide dismutase (EC-SOD) expression in transgenic chicken |
| Q36289736 | In vitro meat production system: why and how? |
| Q36946940 | Ingestion of milk containing the Dp2 peptide, a dust mite allergen, protects mice from allergic airway inflammation and hyper-responsiveness |
| Q49912950 | Intratesticular injection followed by electroporation allows gene transfer in caprine spermatogenic cells |
| Q38850735 | Knock-in fibroblasts and transgenic blastocysts for expression of human FGF2 in the bovine β-casein gene locus using CRISPR/Cas9 nuclease-mediated homologous recombination |
| Q34424075 | Knock-in of Enhanced Green Fluorescent Protein or/and Human Fibroblast Growth Factor 2 Gene into β-Casein Gene Locus in the Porcine Fibroblasts to Produce Therapeutic Protein |
| Q35808466 | Large-Scale Purification of r28M: A Bispecific scFv Antibody Targeting Human Melanoma Produced in Transgenic Cattle |
| Q38115497 | Novel GM animal technologies and their governance. |
| Q36353886 | Oral immunotherapy for pollen allergy using T-cell epitope-containing egg white derived from genetically manipulated chickens |
| Q38428139 | Oviduct-specific enhanced green fluorescent protein expression in transgenic chickens |
| Q52346293 | PhosphoLipid transfer protein (PLTP) exerts a direct pro-inflammatory effect on rheumatoid arthritis (RA) fibroblasts-like-synoviocytes (FLS) independently of its lipid transfer activity. |
| Q37438883 | Plants as bioreactors for the production of vaccine antigens. |
| Q35223799 | Plasma proteomic profiles of bovine growth hormone transgenic mice as they age. |
| Q56569049 | Production of functional human CuZn-SOD and EC-SOD in bitransgenic cloned goat milk |
| Q43298959 | Production of recombinant human erythropoietin/Fc fusion protein by genetically manipulated chickens |
| Q51119286 | Production of transgenic dairy goat expressing human α-lactalbumin by somatic cell nuclear transfer. |
| Q55524178 | Prospectus of cultured meat—advancing meat alternatives. |
| Q57345827 | Protein Therapeutic: Production, Application, and Future Scenario |
| Q51762258 | Protein profile and alpha-lactalbumin concentration in the milk of standard and transgenic goats expressing recombinant human butyrylcholinesterase. |
| Q92542772 | Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development |
| Q39148639 | Recent advances in (therapeutic protein) drug development. |
| Q38261152 | Recent developments in therapeutic protein expression technologies in plants. |
| Q39849349 | Recombinant human antithrombin expressed in the milk of non-transgenic goats exhibits high efficiency on rat DIC model. |
| Q33736142 | Recombinant human factor IX produced from transgenic porcine milk |
| Q33780365 | Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis. |
| Q37742184 | Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces |
| Q47129023 | Secretion of a recombinant protein without a signal peptide by the exocrine glands of transgenic rabbits |
| Q34971872 | Stem cells in veterinary medicine |
| Q36039890 | Targeting Human α-Lactalbumin Gene Insertion into the Goat β-Lactoglobulin Locus by TALEN-Mediated Homologous Recombination |
| Q43268796 | Tetracycline-dependent expression of the human erythropoietin gene in transgenic chickens |
| Q38311132 | The history of monoclonal antibody development - Progress, remaining challenges and future innovations |
| Q39692952 | The recombinant chimeric antibody chHAb18 against hepatocellular carcinoma can be produced in milk of transgenic mice |
| Q38714835 | The transgenic animal platform for biopharmaceutical production |
| Q37138938 | The use of lectin microarray for assessing glycosylation of therapeutic proteins |
| Q38057179 | Therapeutic application of monoclonal antibodies in cancer: advances and challenges |
| Q37923355 | Transduction of human recombinant proteins into mitochondria as a protein therapeutic approach for mitochondrial disorders |
| Q33893351 | Transgenic mouse technology: principles and methods |
| Q37009481 | Transient Expression of Tetrameric Recombinant Human Butyrylcholinesterase in Nicotiana benthamiana. |
| Q36730328 | Use of transgenic animals in biotechnology: prospects and problems |
| Q33909140 | Vaccination of rabbits with an alkylated toxoid rapidly elicits potent neutralizing antibodies against botulinum neurotoxin serotype B. |